Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation

This publication has 24 references indexed in Scilit:

• Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry
  Cardiovascular Intervention and Therapeutics, 2012
• Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
  Circulation, 2012
• Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials
  European Heart Journal, 2012
• Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents
  Circulation, 2012
• Standardized Bleeding Definitions for Cardiovascular Clinical Trials
  Circulation, 2011
• Clopidogrel with or without Omeprazole in Coronary Artery Disease
  New England Journal of Medicine, 2010
• Incidence, Predictors, and Prognostic Implications of Hospitalization for Late Bleeding After Percutaneous Coronary Intervention for Patients Older Than 65 Years
  Circulation: Cardiovascular Interventions, 2010
• Clinical End Points in Coronary Stent Trials
  Circulation, 2007
• Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents
  New England Journal of Medicine, 2007
• Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
  New England Journal of Medicine, 2002